EMA Drafts ‘Strengthened’ Guidance on Safety Follow-Up for Advanced Therapies

Drug Industry Daily
A A
The European Medicines Agency released a draft revised guideline for safety and efficacy follow-up of advanced therapy medicinal products, including gene therapies, cell therapies and tissue engineering.

To View This Article:

Login

Subscribe To Drug Industry Daily